RaySearch Laboratories AB (publ) (FRA:27R)

Market Cap	602.30M -20.7%
Revenue (ttm)	124.22M +12.8%
Net Income	21.05M +11.9%
EPS	0.61 +12.0%
Shares Out	n/a
PE Ratio	28.61
Forward PE	24.64
Dividend	0.28 (1.57%)
Ex-Dividend Date	May 23, 2025

Volume	n/a
Average Volume	5
Open	17.58
Previous Close	17.58
Day's Range	17.58 - 17.58
52-Week Range	15.74 - 32.70
Beta	n/a
RSI	45.42
Earnings Date	Feb 12, 2026

About RaySearch Laboratories AB

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation...

• Industry: Prepackaged Software
• Founded: 2000
• Employees: 458
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 27R

Financial Performance

In 2025, RaySearch Laboratories AB's revenue was 1.34 billion, an increase of 12.77% compared to the previous year's 1.19 billion. Earnings were 227.80 million, an increase of 11.93%.

Financial numbers in SEK